BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//KESHO - ECPv6.16.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://kesho-kenya.org
X-WR-CALDESC:Events for KESHO
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Africa/Nairobi
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0300
TZNAME:EAT
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20230511T180000
DTEND;TZID=Africa/Nairobi:20230511T210000
DTSTAMP:20230620T114938Z
CREATED:20230524T215055Z
LAST-MODIFIED:20230620T114938Z
UID:7855-1683828000-1683838800@kesho-kenya.org
SUMMARY:Clinical Research in Breast Cancer
DESCRIPTION:[vc_row][vc_column][vc_column_text]SPEAKER PROFILES: \nDr Njoki Njiraini \nNjoki Njiraini is a Consultant Clinical Oncologist based at the Kenyatta National Hospital. \nShe has been key in instituting multidisciplinary meetings\, problem oriented research in the department\, and streamlining patient care within the oncology clinics in the public and private sector. \nDr Njiraini holds a Bachelor’s Degree in Medicine and Surgery from the University of Nairobi\, a Master’s Degree in Radiation Oncology from the University of Cape Town\, is a Fellow of the College of Radiation Oncology (FCRO) South Africa and a graduate of the Harvard POETIC Fellowship programme. \nProf Mansoor Saleh \nMansoor Saleh\, MD received his early education in the Aga Khan School system in East Africa\, his medical education at the University of Heidelberg in Germany and conducted his doctoral research at the Max Planck Institute for Medical Research in Heidelberg. He received his training in internal medicine at the Henry Ford Hospital in Detroit Michigan and clinical and translational research training in Hematology & Oncology at the University of Alabama Comprehensive Cancer Center in Birmingham\, Alabama where he was tenured Professor of Medicine & Pathology and Director of the First-in-Human Early Drug Development Program. \nHis area of research and clinical focus is “targeted therapy of cancer”. In January 2020\, he joined the Aga Khan University in Nairobi\, Kenya as the Founding Chair\, Department of Hematology – Oncology and Founding Director – AKU\, N Cancer Center. \nModerator: Dr Regina Nanzia \nRegina Nanzia Ojiwa is a Consultant Clinical Oncologist based at the Cancer Treatment Centre in Kenyatta National Hospital. \nShe holds a Bachelor’s degree in Medicine and Surgery from Moi University and a Master’s degree in Clinical Oncology and Nuclear Medicine from Alexandria University\, Egypt. \nDr Nanzia has key interest in Esophageal\, Colorectal and Prostate cancer.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column]    \n    	\n                	Recording                \n        \n    \n    [vc_column_text][vc_row][vc_column][vc_message]Dear Guest\, this content is restricted to only KESHO Members.[/vc_message][vc_row_inner][vc_column_inner width="1/3"]    	\n        Access our Membership Page        \n        [/vc_column_inner][vc_column_inner width="1/3"]    	\n        Fill in the Membership Form        \n        [/vc_column_inner][vc_column_inner width="1/3"]    	\n        Access Membership Portal        \n        [/vc_column_inner][/vc_row_inner][/vc_column][/vc_row] \n[/vc_column_text][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/clinical-research-in-breast-cancer/
CATEGORIES:CME 2023,Continuing Medical Education (CME),Webinar Recording Available
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2023/05/unnamed-5.jpg
END:VEVENT
END:VCALENDAR